MMI-0100

· Moerae Matrix, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MMI-0100, covering 2017-04-07 to 2017-04-07. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1a Study in Healthy Smokers to Investigate the Effect With MMI-0100 on Airway Inflammation in Induced Sputum After Challenge With Inhaled Lipopolysaccharide [Phase 1]

See pricing